Skip to main navigation
Skip to search
Skip to main content
Sort by
Immunology and Microbiology
Adjuvant
10%
Agonist
10%
Bagg Albino Mouse
9%
BCG Vaccine
14%
Cell Function
10%
Chemokine Receptor
12%
Cytokine
8%
Cytotoxic T-Cell
7%
Dendritic Cell
8%
Drug Resistance
15%
Granuloma
9%
Host Immune Response
6%
Immune Landscape
7%
Immune Response
28%
Immunomodulation
9%
Infection
82%
Infectious Agent
11%
Infectious Disease
82%
Inflammation
7%
Innate Lymphoid Cell
14%
interferon
16%
Interleukin 10
14%
Interleukin 17
12%
Kinase
7%
Leishmania
9%
Leishmania donovani
7%
Leishmaniasis
14%
Lipoarabinomannan
9%
Lung
30%
Macrophage
40%
Monocyte
15%
Mouse Model
16%
Mycobacterium Bovis BCG
9%
Mycobacterium Indicus Pranii
14%
Mycobacterium Tuberculosis
83%
Myeloid
6%
Myocarditis
8%
Outbred Mouse Strain
6%
Phosphotransferase
7%
Promoter Region
8%
Protein Kinase C
9%
Regulatory T Cell
9%
Severe Acute Respiratory Syndrome Coronavirus 2
9%
Susceptible Host
8%
T Cell
13%
T-Helper Cell
8%
TLR2
16%
TLR4
10%
Upregulation
9%
Visceral Leishmaniasis
8%
Keyphrases
Antileishmanial
8%
Balb C Mice
8%
CCR2
7%
Drug Resistance
19%
Granuloma
8%
Group 3 Innate Lymphoid Cells
9%
Heart Failure
12%
Host Immunity
7%
ILC3
13%
Immune Landscape
8%
Immune Response
9%
Immunomodulation
9%
Innate Lymphoid Cells
8%
Interferon-α (IFN-α)
11%
Interleukin-10
13%
Interleukin-17 (IL-17)
12%
Intracellular Signaling
9%
L. Donovani
8%
Leishmania
7%
Leishmania Donovani
16%
Lipoarabinomannan
9%
Lung
25%
Macrophages
19%
Mouse Model
20%
Mucosal Vaccine
7%
Mycobacterium Indicus Pranii
14%
Mycobacterium Tuberculosis (M. tb)
100%
Mycobacterium Tuberculosis Infection
29%
NF-B
9%
Protective Immune Response
13%
Protective Immunity
11%
Protein Kinase C
8%
Receptor 2
10%
Regulatory T (Treg) Cells
9%
Rifampicin
10%
RpoB Gene
9%
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
8%
T Cell Activation
10%
Th17 Response
8%
Toll-like
17%
Trained Immunity
9%
Tuberculosis Control
16%
Tuberculosis Disease
9%
Tuberculosis Infection
9%
Tuberculosis Vaccine
18%
Vaccination
7%
Vaccine Effectiveness
7%
Vaccine Response
10%
Vaccine-induced Immunity
8%
Visceral Leishmaniasis
8%